Thomas Jefferson University Researchers Discover New Pathways that Drive Metastatic Prostate Cancer | Inbound marketing, social and SEO | Scoop.it
Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December 21...Read the whole entry... »...

Via Brian Shields, Ray and Terry's